Monday, November 23, 2009

Natural selection among us: The Kuru epidemic

Kuru is an acquired prion disease, transmitted through ritualistic cannibalism, that reached epidemic proportions in the Fore tribe of Papua New Guinea.  In a previous post, I presented an article by John Collinge’s group on the selection process of heterozygosity at codon 129 of the prion protein gene (PRNP).  The research group has gone a step further by recently describing a new polymorphism of the PRNP gene, G129V.

The authors performed PRNP genotyping of 3,000 individuals from the Eastern Highland population, which included 709 individuals who had participated in cannabalistic rituals.  They looked specifically at the codons 127 and 129 among geographic regions and among individuals that were stratified by risk exposure (i.e., high, medium, and low risk). 

The G127V variant was only found in those regions where kuru was prevalent.  127V was present in half of the women who had the highest exposure to kuru and who were homozygous for methionine at codon 129 (MM).   Interesting, although 129V was present in kuru exposed populations, it was not found in those who succumbed to kuru or in unexposed population groups around the world.  127V was also invariably linked to a 129M allele and predominately found in 129MM homozygotes in contrast to 129MV heterozygotes.  Heterozygosity at codon 127 thus conveyed resistance to kuru in others susceptible 129MM homozygotes.  

Thus the newly described G127V polymorphism was naturally selected among populations exposed to kuru as a resistance factor.  Both codon 129V and codon 127V are examples of natural selection that have occurred recently. 

Once again, prion diseases teach us a lot about biology in general…hence another important factor for studying them. 

ResearchBlogging.org Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T, Al-Dujaily H, Hummerich H, Beck J, Mein CA, Verzilli C, Whittaker J, Alpers MP, & Collinge J (2009). A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure. The New England journal of medicine, 361 (21), 2056-2065 PMID: 19923577

 

 


Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Tuesday, November 17, 2009

NeuroPrion Prion 2009 Newsletter

The NeuroPrion’s Prion 2009 special edition newsletter is now out.  It covers all of the events of the Prion 2009 events that was held in Greece in September.  You can read the newsletter here


Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Saturday, November 14, 2009

Prions activate neuronal cholesterogenic gene expression

Herman Schatzl, who recently received an endowed chair at the University of Wyoming, and colleagues published an article in The Journal of Biological Chemistry early this year on the effects of prion proteins on the expression of cholesterol-associated genes. 

The experiment was an in vitro study using cultured neurons that were infected with the 22L prion strain.  They examined gene expression of genes involved in the cholesterol pathway in neurons and supportive cells.

The authors found increased transcript levels of at least 9 enzymes within the cholesterol synthesis pathway that was confirmed with real time PCR.

image

Upregulation of theses genes was caused by a prion-dependent increase in the activity and amount of the sterol regulatory element-binding protein (Srebp2), which caused elevated levels of free and total cholesterol.  Srebp2 also regulates the expression of low density lipoprotein receptors, which is the main receptor for acquiring extracellular cholesterol.

image

Moreover, downregulation of Srebp2 using siRNA in the absence of exogenous cholesterol decreased prion protein formation compared to cells without siRNA.  When external cholesterol was addeded, prion protein levels remained unchanged between cells with and without siRNA.

The activation of these genes was specific to neurons, as it was not observed in supportive cells including microglia and astrocytes. 

These results suggest that prion propagation is associated with cholesterol and that neuronal cells respond to prion infection by upregulating genes involved in cholesterol synthesis.  This raises the possibility of using cholesterol modification for treatment purposes, however, this is complicated by the fact that most brain cholesterol is synthesized locally as plasma lipoproteins are restricted from crossing the blood/brain barrier. 

ResearchBlogging.org Bach C, Gilch S, Rost R, Greenwood AD, Horsch M, Hajj GN, Brodesser S, Facius A, Schädler S, Sandhoff K, Beckers J, Leib-Mösch C, Schätzl HM, & Vorberg I (2009). Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. The Journal of biological chemistry, 284 (45), 31260-9 PMID: 19748890

Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Friday, November 13, 2009

CJD Foundation Podcast #2 is available

The CJD Foundations second podcast is now available on their website (and soon on iTunes).  We interview Dr. Pierluigi Gambetti, Director of the National Prion Disease Pathology Surveillance Center in this episode.  Please give us feedback as to what you think about the podcasts.


Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Thursday, November 12, 2009

International CJD Day

Today is international CJD day/week. Please take a moment to reflect on those who have lost their life to this disease. CJD Aware! also has a list of several activities that are planned for this week. Please show your support.


Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Tuesday, November 10, 2009

CJD Foundation November Newsletter

The CJD Foundation just released their new newsletter (see below). Note that they are doing their second podcast tomorrow and they have released the dates of next years CJD Foundation Family Conference. CJDF November 2009 Newsletter

Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Monday, November 9, 2009

New issue of Prion is out

The fall-winter addition of the journal Prion is now out. 

There are several articles on the role of prions in neurodegenerative disorders and neuroprotection.  Another article looks at the de nova synthesis of prions in mammals and there is a review article on in vitro studies of the transmission barrier in prion diseases.  I will hopefully have a synopsis of some of these articles in the next couple of weeks.

PRION3-4cover


Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Tuesday, November 3, 2009

Components of green tea interfere with the physiologic role of the native prion protein and its conversion into the pathologic prion protein

As I continue to catch up on my articles, this post is about an article by Rambold and colleagues that was published in the Journal of Neurochemistry.

The researchers’ study was designed to identify compounds that would interfere with the propagation of the pathologic prion protein. The two compounds investigated in the present article were the main components of green tea, epigallocatechin gallate (EGCG) and gallocatechin gallate (GCG).

This was an in vitro study that used scrapie-infected N2a (ScN2a) cells. Both EGCG and GCG reduced pathological prion protein in addition to decreasing native prion proteins. In comparison to similar compounds, the authors found that the gallate side chain was necessary for antiprion activity and that an additional hydroxyl group of the trihydroxyphenyl side chain increased depletion of native prion proteins.

Their data also indicated that EGCG induced a conformational change in the native prion protein at the plasma membrane that resulted in a transitional conformation that led to internalization and lysosomal degradation. Thus native prion proteins were depleted which also resulted in a reduction of the pathologic prion proteins.

An interesting side point was that EGCG decreased the stress-protective function of the native prion protein in uninfected cells. EGCG-treated cells showed an increased vulnerability to stressful conditions (i.e., subjected to excitotoxin kainate, an apoptotic agent)

In summary, EGCG and GCG induces a conformation change of the native prion protein that causes it to be internalized and degraded, thereby decreasing its conversion to pathologic prion protein. In this process, the stress-protective activities of the native prion protein are diminished. Once again, the conundrum of pathologic function +/- loss of function questions emerge as the etiologic cause of the neuropathologic process in prion diseases.

ResearchBlogging.org Rambold, A., Miesbauer, M., Olschewski, D., Seidel, R., Riemer, C., Smale, L., Brumm, L., Levy, M., Gazit, E., Oesterhelt, D., Baier, M., Becker, C., Engelhard, M., Winklhofer, K., & Tatzelt, J. (2008). Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP Journal of Neurochemistry, 107 (1), 218-229 DOI: 10.1111/j.1471-4159.2008.05611.x


Editor's Selection IconThis post was chosen as an Editor's Selection for ResearchBlogging.org

Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Monday, November 2, 2009

A layman’s experience of CJD research

I happened across a nice little editorial that was published last year in the British Medical Journal that I am saddened to have not seen sooner.  It is a piece written by a father of a 25-year-old who died of variant Creutzfeldt-Jakob disease (vCJD).  In this short piece, he describes his experience of being involved in several advisory committees on the treatment of human prion diseases as a layperson.  I would like to highlight a few of his comments.

First, he was surprised to find out that it was relatively “cutting-edge” to have a layperson involved in the research of clinical trials.  And this is in fact true with the exception of some private organizations.  He also notes that some researchers were not happy with his appointment, but he took it in stride.  After surviving some of the bureaucracy that comes with clinical research, he came to several conclusions:

  1. if emerging therapy does not receive institutional support, then it is easy for it to reside outside of the institution's embrace (I would say the same for particularly diseases)
  2. National collaboration is essential given the low incidence of CJD cases-he discusses the political nature of having two national organizations work together on a project
  3. involvement of laypersons should be welcomed by researchers
  4. one must first analyze existing research prior to planning new research
  5. “Academic status and fiefdoms must take second place to patients’ interests, particularly when funding for research is coming from the public purse, and there must be a totally open culture of sharing and publication” (my personal favorite)
  6. citizens should be encouraged to learn more about clinical trials and to participate in them as a public service

Although my research often overlaps with caregivers, I find discussing my research with laypersons one of the most gratifying pieces to doing clinical research.  I also tend to agree with having some layperson involvement on clinical research committees, much like how members of the general public are often included on institutional review boards.  

I’m hoping to get a lot of feedback from this post, so please share your comments below.

del.icio.us Tags: ,,,
ResearchBlogging.org Firkins, L. (2008). The problem in setting research priorities: a layman's experience BMJ, 337 (jul04 1) DOI: 10.1136/bmj.a212

Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy

Sunday, November 1, 2009

October’s most popular posts

Here is a list of October’s most popular posts:

  1. Prion infectivity follows FFI mutation in mice
  2. Evidence that supports the prion hypothesis
  3. Anti-prion activity of amphotericin analogues
  4. The evolution of genetic susceptibility to kuru
  5. Canadians view of BSE

Digg Technorati del.icio.us Stumbleupon Reddit Blinklist Furl Spurl Yahoo Simpy